U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.
about
A review of a family of ultra-rapid-acting insulins: formulation development[Fast-acting insulin - new developments towards more flexibility for the patient].Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.Design of non-standard insulin analogs for the treatment of diabetes mellitusAcceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device.Ultrafast-acting insulins: state of the artInsulin therapies: Current and future trends at dawn.Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices.Moving toward the ideal insulin for insulin pumps.Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.Ultra-rapid absorption of recombinant human insulin induced by zinc chelation and surface charge masking.
P2860
Q26823197-1846C705-6DBA-4D81-873B-C4B101A3BF65Q30313628-44EA575E-D942-4CA6-AF14-60009FC19CBFQ35988978-2B1AF8E8-9136-475F-9B90-7656B698DE92Q36229266-73168457-934C-4FF5-B691-FB7676AD767FQ36374363-40DA70A2-5001-4B67-A239-B7A60E7704CDQ36609298-B663F482-966A-4241-918D-C02FC212BB60Q38037727-99A4A420-273C-4E2F-BC97-B6D49EC38878Q38089594-A9AEE643-3099-44D2-80F6-C00C0BE03DFBQ38578266-3267AAB4-C775-4128-8308-DB19AD086434Q38631154-21E41205-86EB-4A7E-B886-4C9DB3D5C81AQ38750029-FA02C7B1-C551-4F6D-8806-50E88E12EC7FQ42268809-F2CC4041-F297-4538-9E5B-A56065093105
P2860
U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
U-100, pH-Neutral formulation ...... patients with type 1 diabetes.
@en
U-100, pH-Neutral formulation ...... patients with type 1 diabetes.
@nl
type
label
U-100, pH-Neutral formulation ...... patients with type 1 diabetes.
@en
U-100, pH-Neutral formulation ...... patients with type 1 diabetes.
@nl
prefLabel
U-100, pH-Neutral formulation ...... patients with type 1 diabetes.
@en
U-100, pH-Neutral formulation ...... patients with type 1 diabetes.
@nl
P2093
P2860
P1476
U-100, pH-Neutral formulation ...... patients with type 1 diabetes.
@en
P2093
L Heinemann
P Pichotta
P2860
P304
P356
10.1111/J.1463-1326.2011.01516.X
P577
2011-11-13T00:00:00Z